The next major release, .NET 11, should arrive in November 2026, and the project recently unveiled its first public preview. Like earlier first looks, it’s nowhere near feature complete, with several ...

Understand the key advantages of Razor Pages in ASP.NET Core for building real-world web applications Learn how features like dependency injection, configuration, and environment awareness improve ...

We’re several days beyond Groundhog Day, but even in February, the Red Wings goalie problems still feel like a game of whack-a-mole as they keep getting tripped up by old shadows. They’ve known a ...

January was supposed to be quiet at Anfield. Instead, Liverpool supporters found themselves squinting at their screens as reports emerged that Curtis Jones, a homegrown midfielder fresh from a title ...

There’s a special kind of dread that comes from a place that looks perfectly ordinary—until you realize it won’t let you leave. That’s the trap at the center of NEON’s newly unveiled trailer for “Exit ...

"Are you lost?" Neon has debuted their own official US language trailer for the Japanese film Exit 8, a time loop horror thriller from filmmaker Genki Kawamura. This film is legit! It premiered at the ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Elon Musk says social platform X will open-source a new recommendation algorithm within seven days, exposing all code behind organic and ad post suggestions and updating it every four weeks with ...

Bowen Yang is sitting down for his "SNL" exit interview. The "Wicked" star, 35, opened up on the Jan. 7 episode of his "Las Culturistas" podcast with Matt Rogers about his decision to leave "Saturday ...

Speculation has a habit of gathering around players who appear caught between promise and opportunity. Federico Chiesa finds himself in that space once more, his Liverpool career still searching for ...

After doubling InfuCare’s EBITDA value over the last three years, One Equity Partners still sees “tremendous runway and consolidation opportunities” in the home infusion therapy markets for further ...